A Common Warning Letter Citation Explored
A review of Warning Letters issued in 2023 and 2024 (to date) by the U.S. FDA to manufacturers of drug products and cosmetics shows the presence of some findings that are seen more frequently than others. One of these is the following: “Your firm failed to test samples of each component for conformity with all […]